Latest News and Press Releases

PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner

PharmAla completes shipment of MDMA to University of Washington, to be used in a Narcissism clinical trial. It also appoints Ali Taghva as CCO.

PharmAla opens the European Market for MDMA, signs Duchefa Farma as its first national-level distributor for LaNeo MDMA in Europe

PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial

PharmAla to supply the STRONG STAR Consortium with new 20mg MDMA dose to treat active-duty military personnel in a clinical trial

PharmAla adds Matthew Azrieli to Advisory Team

PharmAla releases its Q1 financial statements

PharmAla partners with Merhavim and MAPS Israel for innovative MDMA PTSD clinical trial data sharing partnership in wake of Gaza Ceasefire

PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement

PharmAla announces private placement financing